ALANA EMERICH: Open Payments
NPI 1740690122 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 28 payments from 13 companies in 2025. Trend: 2023 $874 · 2024 $1,562 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $134 |
| Ardelyx, Inc. | 5 | $125 |
| ABBVIE INC. | 4 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Madrigal Pharmaceuticals | 1 | $28 |
| QOL Medical, LLC | 1 | $26 |
| Lilly USA, LLC | 1 | $26 |
| GENZYME CORPORATION | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: TREMFYA, IBSRELA, DUPIXENT, XIFAXAN, LINZESS, RINVOQ, REZDIFFRA, Sucraid.
Industry payments across GA — which companies pay providers there.
